Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia

BACKGROUND: Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely available sodium s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS Negl Trop Dis
Glavni autori: van Henten, Saskia, Tesfaye, Annisa Befekadu, Abdela, Seid Getahun, Tilahun, Feleke, Fikre, Helina, Buyze, Jozefien, Kassa, Mekibib, Cnops, Lieselotte, Pareyn, Myrthe, Mohammed, Rezika, Vogt, Florian, Diro, Ermias, van Griensven, Johan
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2021
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191986/
https://ncbi.nlm.nih.gov/pubmed/34048461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009460
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items